(2328664), J. L., (3520346), K. S., (36889), W. H., (1611796), Q. S., (12001241), Y. Q., (2027), Z. Z., . . . (3833092), E. D. (2025). Table 1_The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer.xlsx.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(2328664), Jingxian Li, Kun Shan (3520346), Wei Huang (36889), Qiang Su (1611796), Yuanjiong Qi (12001241), Zhihong Zhang (2027), Jianqiang Zhu (1669477), و E. Du (3833092). Table 1_The Combination Treatment of RC48 and STAT3 Inhibitor Acts as a Promising Therapeutic Strategy for Basal Bladder Cancer.xlsx. 2025.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(2328664), Jingxian Li, et al. Table 1_The Combination Treatment of RC48 and STAT3 Inhibitor Acts as a Promising Therapeutic Strategy for Basal Bladder Cancer.xlsx. 2025.